DexCom, Inc. DXCM is well-poised for growth in ... company’s shares have lost 36.5% year to date against the industry’s 6.7% growth. The S&P 500 Index has soared 28.6% in the same time frame.

DexCom's devices are incredibly valuable to diabetes patients. The company should continue to increase its addressable market. The stock's valuation looks as reasonable as it has in almost three ...

DexCom DXCM has been analyzed by 9 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish. The table below offers a condensed view of their recent ...

Investing.com -- DexCom Inc (NASDAQ:DXCM) shares up more than 2% following updated guidelines by the American Diabetes Association (ADA), which now recommend using continuous glucose monitors ...

Partnership will enable two-way data flow between Dexcom glucose biosensors and apps ... to launch in the first half of 2025. “Ninety-seven percent of Oura Members have expressed interest ...

In a report released yesterday, Larry Biegelsen from Wells Fargo maintained a Buy rating on Dexcom (DXCM – Research Report), with a price target of $90.00. Don't Miss our Black Friday Offers ...